Apyx Medical Corporation

NASDAQ: APYX · Real-Time Price · USD
2.14
0.02 (0.94%)
At close: Aug 15, 2025, 9:58 AM

Apyx Medical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
48.1M 52.35M 44.51M 48.52M
Cost of Revenue
18.74M 18.59M 15.38M 14.92M
Gross Profit
29.36M 33.76M 29.13M 33.6M
Operating Income
-18.84M -17.26M -23.56M -14.45M
Interest Income
1.61M 921K 157K 11K
Pretax Income
-23.31M -21.28M -22.91M -14.82M
Net Income
-23.46M -18.71M -23.28M -15.2M
Selling & General & Admin
43.13M 48.87M 48.15M 43.73M
Research & Development
5.08M 4.84M 4.54M 4.32M
Other Expenses
n/a -2.69M n/a n/a
Operating Expenses
48.2M 51.02M 52.69M 48.05M
Interest Expense
5.91M 2.48M 15K 10K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
66.95M 69.61M 68.07M 62.97M
Income Tax Expense
252K -2.43M 367K 380K
Shares Outstanding (Basic)
35.54M 34.62M 34.52M 34.33M
Shares Outstanding (Diluted)
35.54M 34.62M 34.52M 34.33M
EPS (Basic)
-0.66 -0.54 -0.67 -0.44
EPS (Diluted)
-0.66 -0.54 -0.67 -0.44
EBITDA
-16.8M -18.11M -22.01M -13.91M
EBIT
-17.4M -18.8M -22.9M -14.81M
Depreciation & Amortization
599K 692K 890K 903K